Home/Filings/4/0001410939-22-000130
4//SEC Filing

Gibney Anthony S 4

Accession 0001410939-22-000130

CIK 0001410939other

Filed

Dec 13, 7:00 PM ET

Accepted

Dec 14, 4:28 PM ET

Size

11.0 KB

Accession

0001410939-22-000130

Insider Transaction Report

Form 4
Period: 2022-12-13
Gibney Anthony S
EVP, Chief Business Officer
Transactions
  • Exercise/Conversion

    Common Stock

    2022-12-13+6,00017,791 total
  • Exercise/Conversion

    Common Stock

    2022-12-13+25,00042,791 total
  • Exercise/Conversion

    Restricted Stock Units

    2022-12-136,0000 total
    Common Stock (6,000 underlying)
  • Exercise/Conversion

    Restricted Stock Units

    2022-12-1325,00075,000 total
    Common Stock (25,000 underlying)
Footnotes (4)
  • [F1]Each restricted stock unit represents the contingent right to receive one share of common stock upon vesting of the unit.
  • [F2]This total includes 832 shares acquired by the Reporting Person on September 15, 2022, under the Registrant's 2016 Employee Stock Purchase Plan that were not previously reported.
  • [F3]On December 13, 2021, the Reporting Person was granted 6,000 restricted stock units, which vested on the first anniversary of the grant date with respect to 100% of the shares.
  • [F4]Subject to continued employment with the Registrant and the other terms and conditions under the Registrant's 2019 Inducement Stock Incentive Plan, the award of restricted stock units will vest with respect to 25% of the shares subject to the award on each of the first, second, third and fourth anniversaries of the grant date.

Issuer

IVERIC bio, Inc.

CIK 0001410939

Entity typeother

Related Parties

1
  • filerCIK 0001750132

Filing Metadata

Form type
4
Filed
Dec 13, 7:00 PM ET
Accepted
Dec 14, 4:28 PM ET
Size
11.0 KB